Peng GS

References (2)

Title : A 48-Week, Multicenter, Open-Label, Observational Study Evaluating Oral Rivastigmine in Patients with Mild-to-Moderate Alzheimer's Disease in Taiwan - Chang_2019_Adv.Ther_36_1455
Author(s) : Chang CC , Peng GS , Lai TJ , Li CH , Liu CK
Ref : Adv Ther , 36 :1455 , 2019
Abstract : Chang_2019_Adv.Ther_36_1455
ESTHER : Chang_2019_Adv.Ther_36_1455
PubMedSearch : Chang_2019_Adv.Ther_36_1455
PubMedID: 30953330

Title : Real-world evaluation of compliance and preference in Alzheimer's disease treatment: an observational study in Taiwan - Lai_2016_Patient.Prefer.Adherence_10_383
Author(s) : Lai TH , Wang WF , Yip BS , Yang YW , Peng GS , Tsai SJ , Liao YC , Pai MC
Ref : Patient Prefer Adherence , 10 :383 , 2016
Abstract : Lai_2016_Patient.Prefer.Adherence_10_383
ESTHER : Lai_2016_Patient.Prefer.Adherence_10_383
PubMedSearch : Lai_2016_Patient.Prefer.Adherence_10_383
PubMedID: 27099476